KGGIX
Price
$16.17
Change
-$0.14 (-0.86%)
Updated
Jun 10 closing price
Net Assets
3.24B
TIISX
Price
$14.78
Change
-$0.19 (-1.27%)
Updated
Jun 10 closing price
Net Assets
1.49B
Interact to see
Advertisement

KGGIX vs TIISX

Header iconKGGIX vs TIISX Comparison
Open Charts KGGIX vs TIISXBanner chart's image
KGGIX vs TIISX Comparison Chart in %
View a ticker or compare two or three
VS
KGGIX vs. TIISX commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KGGIX is a Hold and TIISX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
KGGIX has more cash in the bank: 3.24B vs. TIISX (1.49B). KGGIX pays higher dividends than TIISX: KGGIX (5.13) vs TIISX (3.89). KGGIX was incepted earlier than TIISX: KGGIX (13 years) vs TIISX (10 years). KGGIX (1.01) is less costly to investors than TIISX (0.71). TIISX is a more actively managed with annual turnover of: 112.00 vs. KGGIX (56.00). KGGIX (1000000) and TIISX (1000000) have matching initial minimum investment requirements. TIISX annual gain was more profitable for investors over the last year : 24.88 vs. KGGIX (20.56). TIISX return over 5 years is better than : 38.40 vs. KGGIX (25.73).
KGGIXTIISXKGGIX / TIISX
Total Expense Ratio1.010.71142%
Annual Report Gross Expense Ratio1.010.71142%
Fund Existence13 years10 years-
Gain YTD5.09014.45035%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.24B1.49B218%
Annual Yield % from dividends5.133.89132%
Returns for 1 year20.5624.8883%
Returns for 3 years61.2671.4386%
Returns for 5 years25.7338.4067%
Returns for 10 years154.99N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DWTX1.500.05
+3.79%
Dogwood Therapeutics Inc
NATR20.470.33
+1.64%
Nature's Sunshine Products
NNN46.300.31
+0.67%
NNN Reit
RANGU10.83N/A
N/A
Range Capital Acquisition Corp
VRDN15.77-0.54
-3.31%
Viridian Therapeutics